Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study

Update your browser to view ScienceDirect.

Request details:

Request ID: 8aac06f31c35cfa8-SJC
IP: 116.62.10.13
UTC time: 2024-07-29T09:19:24+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4